The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 7.91 -0.19 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.10 | 52 Week High | $5.40 | |||
| Open | $7.89 | 52 Week Low | $1.88 | |||
| Day High | $8.17 | P/E | N/A | |||
| Day Low | $7.80 | EPS | $0.00 | |||
| Volume | 858,776 | |||||
